Exotic emerging viral diseases: progress and challenges.
about
A novel rhabdovirus associated with acute hemorrhagic fever in central AfricaVesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesEffective post-exposure treatment of Ebola infectionMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesSmall molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infectionUncovering viral protein-protein interactions and their role in arenavirus life cycleEnvelope glycoprotein of arenavirusesT-705 (favipiravir) inhibition of arenavirus replication in cell cultureAssembly of a functional Machupo virus polymerase complexDengue virus pathogenesis: an integrated viewReporter-Expressing, Replicating-Competent Recombinant ArenavirusesAdvanced vaccine candidates for Lassa feverThe polymerase of negative-stranded RNA virusesViruses and antiviral immunity in DrosophilaPathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic feversProgress in the experimental therapy of severe arenaviral infectionsTranscriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposureDengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproductionGreene SCPrimer: a rapid comprehensive tool for designing degenerate primers from multiple sequence alignmentsProcessing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon InductionDifferences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: Implications for receptor usage and pathogenicityUnusual Molecular Architecture of the Machupo Virus Attachment GlycoproteinStructures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune SuppressionCrystal Structure of Venezuelan Hemorrhagic Fever Virus Fusion Glycoprotein Reveals a Class 1 Postfusion Architecture with Extensive GlycosylationInhibition of Innate Immune Responses Is Key to Pathogenesis by ArenavirusesEffective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverLymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic diseaseEndosomal proteolysis of the Ebola virus glycoprotein is necessary for infectionRapid screening for entry inhibitors of highly pathogenic viruses under low-level biocontainmentFilamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalaseMolecular determinants of Ebola virus virulence in mice.Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses.Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling.Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus.Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infectionsComprehensive multiplex one-step real-time TaqMan qRT-PCR assays for detection and quantification of hemorrhagic fever virusesHemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.T cell-dependence of Lassa fever pathogenesis.Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
P2860
Q21090485-9FF69A14-8CCE-4CE6-8439-B5C89E1CDDABQ21131585-FF069CC3-111B-44BF-979C-D64F270E7654Q21131616-3F71FF2B-8014-4AA3-AA61-6EE5A9B8AA3DQ21562420-A3016131-5BE4-44EE-BA51-B7A2D16DA5CAQ24329155-610068C6-F4CE-4785-9B1C-F5AD9B582561Q24611407-EA1F897C-5D63-4ED4-8599-B26D8B58E369Q24613392-C0575F57-8D5B-4857-A3E3-971DC02EA91DQ24633241-F6AB3E86-4512-4421-BBB0-F558E186FF7DQ24633795-6FFEFC40-DEB4-4BCA-8726-32FE6B1E840AQ24645380-45F4293B-117E-4D7E-BFED-22CEB7B9D51AQ26742028-701D42FA-1F39-4ABA-9E99-13EC9176162DQ26823627-4D0D612B-1D92-4A02-AE90-BDD354F9B8DCQ26824373-AD9F0221-5520-43EE-9876-108445CD6493Q26998819-74CBB7A9-CCCF-49C3-AE33-2909FFCF68F4Q27024900-ABB116F4-6F44-4958-A640-C17E8A47A8D5Q27024953-B0F438F8-C7EE-4D68-8F2D-6C1770B424B5Q27305228-8B694736-7E4D-49EC-A938-F3CD3E97BF84Q27477724-E4A34240-017F-40E2-885D-C10838765D4CQ27477912-4E30DE9C-E56D-4912-9AD0-6CAB55AC1D04Q27485881-8191F415-D7B9-4EF1-AEE9-64F29838C320Q27489608-2D82F6CF-CDEC-48E2-8550-C667DAE341BBQ27655727-42EC4170-C9E6-4C66-8AE2-B6C50DBDF229Q27677547-3F3579C4-BAFC-4784-A765-FE7709446551Q27679988-BA422337-A63A-46FB-97FB-45414CEB6891Q28079141-F9B7915A-2A2B-4426-B73F-7A638862B6AEQ28477434-F8F7FC9F-73FA-4455-85C3-57291D954E03Q28484627-11BB3629-7A23-452F-A62F-AA9BB8DDE904Q28588877-50DEB269-D55B-4D3A-A385-D9BF5468F5FDQ28731583-A434C7CF-C1EC-4990-964B-C5AFDA33B653Q30489269-D4C4725D-2313-4A66-9823-87BADEED2F6AQ33250567-86932B94-4C93-4553-AE26-4BFB4519107EQ33334027-5095B93D-809A-468A-9CB0-E33574CC0FF5Q33389296-A7F2743A-FD9F-43CA-A5A1-1D170977251FQ33400317-6C1C6E57-7393-467B-AC27-A4EDBDB77B48Q33401401-61A78E99-283C-4B0A-912E-CA629605222DQ33405193-4258EE6E-01CF-42D6-B2D2-B24A2BFC2B87Q33414767-CBB93542-0E6C-4723-A6C6-F269EFE74AAFQ33439713-951C3A60-49D4-4C91-9C08-177641F603B0Q33548699-565E55DE-946C-4B0E-8A52-9ED2C4B2ED38Q33558767-98666099-1C1A-4327-8989-BE2A9960ED01
P2860
Exotic emerging viral diseases: progress and challenges.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Exotic emerging viral diseases: progress and challenges.
@ast
Exotic emerging viral diseases: progress and challenges.
@en
type
label
Exotic emerging viral diseases: progress and challenges.
@ast
Exotic emerging viral diseases: progress and challenges.
@en
prefLabel
Exotic emerging viral diseases: progress and challenges.
@ast
Exotic emerging viral diseases: progress and challenges.
@en
P2860
P356
P1433
P1476
Exotic emerging viral diseases: progress and challenges.
@en
P2860
P2888
P304
P356
10.1038/NM1142
P407
P433
P577
2004-12-01T00:00:00Z